The FDA has granted America Stem Cell approval to conduct a Phase I/IIa multicenter dual umbilical cord transplantation study. The nationwide trial will assess the efficacy of the firm's investigational therapy ASC-101 in patients with hematologic malignancies and myelodysplastic syndrome.
FDA gives green light to America Stem Cell transplant trial
SmartBrief Job Listings for Education
|Director of Professional Services||
Engaging Schools, Inc.
|Principal at Emerson Academy of Dayton||
National Heritage Academies
|Program Officer, Teacher Development||
Knowles Science Teaching Foundation
Capitol Region Education Council (CREC)
|Senior ELL Technical Assistance and Curriculum Specialist (8270)||
American Institute for Researcher